Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases

Clinical Cancer Research

Volumn 20, Issue 11, 2014, Pages 2885-2897

  Tseng, Ju Yu ^a   Yang, Chih Yung ^a,b   Liang, Shu Ching ^a   Liu, Ren Shyan ^a,c   Yang, Shung Haur ^a,c   Lin, Jen Kou ^a,c   Chen, Yuh Min ^a,c   Wu, Yu Chung ^a,c   Jiang, Jeng Kai ^a,c   Lin, Chi Hung ^a,b,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d VGH Yang Ming Genome Research Center   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL MOTILITY; CELL SELECTION; CIRCULATING TUMOR CELL; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR DRAINING VEIN; TUMOR INVASION; TUMOR VASCULARIZATION; VEIN; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; BLOOD; COLORECTAL TUMOR; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; TUMOR EMBOLISM; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; KAPLAN-MEIER ESTIMATE; MALE; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84901800888     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-2162     Document Type: Article

References (52)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Gramont A. Adjuvant therapy of stage II and III colon cancer. Semin Oncol 2005;32:11-4.
3. Sengupta N, Gill KA, MacFie TS, Lai CS, Suraweera N, McDonald S, et al. Management of colorectal cancer: a role for genetics in prevention and treatment? Pathol Res Pract 2008;204:469-77.
4. Johnston PG. Stage II colorectal cancer: to treat or not to treat. Oncologist 2005;10:332-4. (Pubitemid 40647251)
5. Yang CY, Lin CH, Jiang JK. Early relapse in a rectal cancer patient: possible implication of circulating cancer stem cell. J Surg Oncol 2010;102:196-7.
6. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274-84.
7. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009;9:302-12.
8. Alix-Panabieres C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med 2012;63:199-215.
9. Bessa X, Elizalde JI, Boix L, Pinol V, Lacy AM, Salo J, et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001;120:1084-92. (Pubitemid 32246662)
10. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, Rafael S, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008;19:935-8. (Pubitemid 351627310)
11. Maestro LM, Sastre J, Rafael SB, Veganzones SB, Vidaurreta M, Martin M, et al. Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res 2009;29:4839-43.
12. Tralhao JG, Hoti E, Serodio M, Laranjeiro P, Paiva A, Abrantes AM, et al. Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer. Eur J Surg Oncol 2010;36:125-9.
13. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006;12:4218-24.
14. Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, et al. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 2007;13:2023-9. (Pubitemid 46649868)
15. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:3213-21.
16. Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008;15:3092-100.
17. Aggarwal C, Meropol NJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol 2012 Oct 1. [Epub ahead of print]
18. Thorsteinsson M, Soletormos G, Jess P. Low number of detectable circulating tumor cells in non-metastatic colon cancer. Anticancer Res 2011;31:613-7.
19. Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK, et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010;6:603-15.
20. Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J, et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A 2010;107:18115-20.
21. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58-65. (Pubitemid 30456551)
22. Iinuma H, Okinaga K, Egami H, Mimori K, Hayashi N, Nishida K, et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 2006;28:297-306.
23. Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol 2009;27:6160-5.
24. Rahbari NN, Bork U, Kircher A, Nimitz T, Scholch S, Kahlert C, et al. Compartmental differences of circulating tumor cells in colorectal cancer. Anna Surg Oncol 2012;19:2195-202.
25. English D, Andersen BR. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 1974;5:249-52.
26. Goodale D, Phay C, Brown W, Gray-Statchuk L, Furlong P, Lock M, et al. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer. Cytometry B Clin Cytom 2009;76:107-17.
27. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009;101:61-6.
28. Tseng W, Leong X, Engleman E. Orthotopic mouse model of colorectal cancer. J Vis Exp 2007;10:484.
29. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
30. Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 2006;6:125-32. (Pubitemid 44445747)
31. Goodale D, Phay C, Postenka CO, Keeney M, Allan AL. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry. Cytometry A 2009;75:344-55.
32. Cespedes MV, Espina C, Garcia-Cabezas MA, Trias M, Boluda A, Gomez del Pulgar MT, et al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 2007;170:1077- 85.
33. Sasaki T, Nakamura T, Rebhun RB, Cheng H, Hale KS, Tsan RZ, et al. Modification of the primary tumor microenvironment by transforming growth factor α-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model. Am J Pathol 2008;173:205-16. (Pubitemid 351947968)
34. Kryczek I, Wei S, Szeliga W, Vatan L, Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009;114:357-9.
35. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009;206:1457-64.
36. Li J, Lau GK, Chen L, Dong SS, Lan HY, Huang XR, et al. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-κB induced matrix metalloproteinases 2 and 9 expression. PLoS ONE 2011;6:e21816.
37. Xu M, Song ZG, Xu CX, Rong GH, Fan KX, Chen JY, et al. IL-17A stimulates the progression of giant cell tumors of bone. Clin Cancer Res 2013;19:4697-705.
38. Wang M, Wang L, Ren T, Xu L, Wen Z. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells. Cancer Biol Ther 2013;14:155-63.
39. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009;9:556-67.
40. Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011;407:348-54.
41. Lindmark G, Gerdin B, Sundberg C, Pahlman L, Bergstrom R, Glimelius B. Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 1996;14:461-6. (Pubitemid 26051008)
42. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-27.
43. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35. (Pubitemid 37328697)
44. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485-517.
45. Korn T, Petermann F. Development and function of interleukin 17-producing γδ T cells. Ann N Y Acad Sci 2012;1247:34-45.
46. Koch M, Kienle P, Hinz U, Antolovic D, Schmidt J, Herfarth C, et al. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg 2005;241:199-205.
47. Midgley R, Kerr D. Colorectal cancer. Lancet 1999;353:391-9. (Pubitemid 29088178)
48. Miller W, Ota D, Giacco G, Guinee V, Irimura T, Nicolson G, et al. Absence of a relationship of size of primary colon carcinoma with metastasis and survival. Clin Exp Metastasis 1985;3:189-96. (Pubitemid 16219654)
49. Hayata K, Iwahashi M, Ojima T, Katsuda M, Iida T, Nakamori M, et al. Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice. PLoS ONE 2013;8:e53131.
50. Oshiro K, Kohama H, Umemura M, Uyttenhove C, Inagaki-Ohara K, Arakawa T, et al. Interleukin-17A is involved in enhancement of tumor progression in murine intestine. Immunobiology 2012;217:54-60.
51. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15. (Pubitemid 351636299)
52. Kalinski P, Urban J, Narang R, Berk E, Wieckowski E, Muthuswamy R. Dendritic cell-based therapeutic cancer vaccines: what we have and what we need. Future Oncol 2009;5:379-90.